Interest in LBBAP on the rise | Heart monitor software recalled for not sending alerts | COVID-induced arrhythmias

The first patient has been enrolled in a new study of an optimized lead for LBBAP, an area with an explosion of interest in EP as a way to improve patient outcomes.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston. 

Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome. 

The American College of Cardiology published an expert consensus on practical approaches for arrhythmia monitoring after stroke to improve post-stroke care by identifying and managing atrial fibrillation.